$45.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Country

US

CEO

Mr. Michael Mahoney

IPO date

1992

Employees

59,000

ISIN

US1011371077

Key stats

Open

$45.08

Volume

12.40M

Market cap

$66.60B

Prev. close

$44.99

Impl / hst vl

-

Open interest

$0.00

$45.00

Day’s Range

$45.08

$42.25

52W Range

$100.90

Valuation

66
Valuation score
Undervalued
P/E
18.63
P/S
3.22
P/B
2.57
Current ratio
1.90
Debt / Equity
0.37
ROE
14.87%
Gross margin
69.34%
Income growth
99.55%
FCF growth
-83.22

Analysts estimates

Consensus rating
Buy

The average rating from top 19 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$79.86
The top 34 analysts forecasts that 12-month price may increase by 77.47%, with a low of $55.55 and a high of $123.90
$55.55
Low
$79.86
Avg
$123.90
High
Current price

Earnings

Q1 ‘26 revenue
$5.20B
Q1 ‘26 net income
$1.34B
Revenue
Net income
Previous EPS
$0.80
Estimate EPS
$0.84
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply